Heart Disease Made Optional

Cardiovascular disease becomes effectively optional through gene therapy and AI-designed drugs.

Evidence:clinicaltrialsopenfdaarxiv Source refresh pending

27.2%progress

Median Predicted Year

2045

P10: 2035 · P90: 2060

Time to Median Prediction

Syncing countdown…

Progress Index Over Time

Proprietary progress score

Prediction Range

P10 / Median / P90 estimates

expertmarketmodel

Why It Moved — Recent Events

46 days soonerJul 30

Hourly data refresh: 22264 active clinical trials.

Automated data refresh

Accelerators & Bottlenecks

What speeds it up

PCSK9 inhibitors

Gene therapy for cholesterol

AI drug discovery

What slows it down

Complex multi-factor disease

Global access to interventions

Forecast methodology: Progress % and predicted years are computed by our proprietary algorithm combining real-money prediction markets (Polymarket, Kalshi), expert forecasts weighted by Brier score accuracy, and hard data trend extrapolation using S-curves fitted to clinical trial progression (ClinicalTrials.gov), AI benchmark scores (HuggingFace), publication velocity (arXiv), and drug approvals (openFDA). P10/P50/P90 represent optimistic, median, and pessimistic scenarios. Updated hourly.